Updated Jul 16, 2026
Bookman Michael is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $7K.
Michael Bookman serves as the Chief Legal Officer and Secretary at Immuneering Corp, a biopharmaceutical company focused on drug development for oncologic and neurologic diseases. He has been involved in the company's legal and regulatory affairs, contributing to its operational framework.
| Role | CHIEF LEGAL OFFICER, SECRETARY |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-01 | IMRX | Immuneering Corp | P — Open-market purchase | 1.0K | $6.83 | $7K |
Michael Bookman serves as the Chief Legal Officer and Secretary at Immuneering Corp, a biopharmaceutical company focused on drug development for oncologic and neurologic diseases. He has been involved in the company's legal and regulatory affairs, contributing to its operational framework.…
Recorded transactions: 1 open-market purchases ($7K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bookman Michael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.